Neural Alteration Response to Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Depressed Patients
- Conditions
- Depression
- Registration Number
- NCT03592446
- Lead Sponsor
- Xidian University
- Brief Summary
Electrical vagus nerve stimulation (VNS) was approved by FDA for treatment of chronic recurrent depression in 2005. Recently, non-invasive, transcutaneous auricular vagus nerve stimulation (taVNS) has already been used for depression treatment. However, the neural mechanism remains unclear, and the relationship between stimulation parameters and neural response were also unknown. The present study aims to investigate the specific brain activation in depression patients after taVNS,compared with healthy controls.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
- Meets ICD-10 diagnosis standard;
- without taking anti-depressive medication or other psychiatric medications 2 weeks before the experiment;
- Patient has exhibited symptoms for at least 2 months, but no longer than 2 years.
- With current addiction to drugs;
- With other severe organic diseases, such as severe heart disease, kidney failure etc;
- disagree with the consent form.
- Cannot receive MRI scan.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method actual neural activation in brain 2 hours By using fMRI technology, the BOLD signal of brain is analyzed.
- Secondary Outcome Measures
Name Time Method Heart rate variability 2 hours Frequency domain methods is used to analyze the bands of frequency and then count the number of NN intervals that match each band. The bands are typically high frequency (HF) from 0.15 to 0.4 Hz, low frequency (LF) from 0.04 to 0.15 Hz, and the very low frequency (VLF) from 0.0033 to 0.04 Hz.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.